Quality Control
The quality of an Antibody-Drug Conjugate (ADC) directly impacts its safety, efficacy, stability, and regulatory compliance. Due to the structural complexity of ADCs, quality control extends beyond conventional biologics testing and requires comprehensive evaluation of critical quality attributes (CQAs), including drug-to-antibody ratio (DAR), conjugation efficiency, payload integrity, aggregation, purity, potency, and residual impurities. Protheragen provides integrated ADC Quality Control (QC) Services throughout the entire product lifecycle, from early process development to clinical manufacturing and commercial production support.
Overview of Quality Control
Antibody-drug conjugates integrate monoclonal antibodies, highly potent cytotoxic payloads, and specialized linker chemistries into a single therapeutic molecule. This structural complexity introduces unique analytical and quality challenges compared with conventional biologics.
Effective quality control ensures that every manufacturing batch consistently meets predefined specifications for identity, purity, potency, safety, and stability. Comprehensive QC testing also plays a critical role in process validation, technology transfer, lot release, stability assessment, and regulatory compliance.
Our Services
Protheragen provides comprehensive quality control solutions covering the entire ADC manufacturing lifecycle, from raw material qualification and in-process testing to final product release, stability studies, analytical method validation, and GMP environmental monitoring. Our integrated quality system ensures product consistency, regulatory compliance, and reliable analytical data throughout every stage of ADC development and manufacturing.
Raw Materials Release Testing
The quality of raw materials directly influences the consistency and safety of antibody-drug conjugates. Before manufacturing begins, Protheragen performs comprehensive release testing on antibodies, linker-payloads, excipients, and other critical starting materials to ensure they comply with predefined quality specifications.
Our testing capabilities include:
- Identity confirmation
- Specific optical rotation
- Assay and content determination
- Residue on ignition
- Sulfate analysis
- Heavy metal testing
- Elemental impurities
- Moisture determination
- Microbial limit testing
- Bacterial endotoxin testing
- Certificate of Analysis (CoA) verification
Intermediate Sample Testing
In-process quality control is essential for maintaining manufacturing consistency and ensuring optimal conjugation performance. Our intermediate testing services provide real-time analytical support throughout the production process.
Testing services include:
- Protein concentration
- Drug-to-antibody ratio (DAR) determination
- Conjugation efficiency
- Product purity analysis
- Aggregation assessment
- Residual free payload monitoring
- Residual antibody analysis
- Bacterial endotoxin testing
- Process impurity monitoring
- In-process release testing
These analyses help identify process deviations early and support process optimization before final product manufacturing.
ADC Drug Substance & Drug Product Release Testing
Comprehensive release testing verifies that ADC drug substances and finished drug products consistently meet regulatory and quality requirements prior to clinical or commercial use.
Release testing includes:
Physicochemical & Product Quality Testing
- Appearance inspection
- Color and clarity
- pH measurement
- Osmolality
- Water content
- Fill volume verification
- Protein concentration
- Purity analysis
- Drug-to-antibody ratio (DAR)
- Free antibody determination
- Free drug determination
- Aggregate analysis
- Fragment analysis
- Charge variant analysis
Biological Activity
- Potency assay
- Target binding activity
- Cell-based bioassays
Microbial & Safety Testing
- Sterility testing
- Bacterial endotoxin
- Bioburden
- Subvisible particulate matter
Drug Substance & Drug Product Stability Testing
A well-designed stability program provides critical evidence supporting product shelf life, storage conditions, and regulatory submissions.
Protheragen offers comprehensive stability studies for both ADC drug substances and finished drug products.
Available studies include:
- Long-term stability studies
- Accelerated stability studies
- Stress stability testing
- Forced degradation studies
- Freeze-thaw stability
- Thermal stability
- Photostability studies
- Shipping simulation studies
- Stability-indicating analytical testing
Our stability data support formulation development, comparability studies, and regulatory filings.
Analytical Method Transfer & Validation
Reliable analytical methods are fundamental to successful technology transfer, GMP manufacturing, and regulatory compliance.
Protheragen develops, optimizes, transfers, qualifies, and validates analytical methods according to ICH Q2(R2), USP, and other international regulatory guidelines.
Method validation parameters include:
- Specificity
- Accuracy
- Precision
- Repeatability
- Intermediate precision
- Linearity
- Analytical range
- Detection limit (LOD)
- Quantitation limit (LOQ)
- Robustness
- System suitability
Our scientists also support analytical method transfer between development laboratories and GMP manufacturing facilities.
GMP Facility Environmental & Utility Monitoring
Maintaining a controlled manufacturing environment is essential for ensuring product quality throughout ADC production. Protheragen provides comprehensive environmental and utility monitoring programs that comply with current GMP requirements.
Monitoring services include:
- Cleanroom environmental monitoring
- Airborne particle monitoring
- Microbial monitoring
- Pharmaceutical water quality testing
- Clean steam monitoring
- Compressed gas monitoring
- Temperature and humidity monitoring
- Differential pressure monitoring
- Facility trend analysis
- Routine environmental qualification
These services help maintain manufacturing consistency and support successful regulatory inspections.
Highlights of Our ADC Quality Control Platform
Our integrated QC platform supports:
- Raw material qualification and release
- Real-time in-process monitoring
- Drug substance and drug product release testing
- Comprehensive physicochemical characterization
- Potency and biological activity assays
- Stability studies throughout product lifecycle
- Analytical method development, transfer, and validation
- GMP environmental and utility monitoring
- Regulatory-compliant analytical documentation
- Batch release and comparability assessment
Analytical Technologies
Protheragen employs advanced analytical platforms to ensure accurate characterization of complex ADC products.
Our instrumentation supports:
- LC-MS and high-resolution mass spectrometry
- icIEF
- UV-Vis spectroscopy
- Dynamic Light Scattering (DLS)
- HPLC / UHPLC
- SEC-HPLC
- Differential Scanning Calorimetry (DSC)
- Surface Plasmon Resonance (SPR)
- Endotoxin and sterility testing platforms
- HIC-HPLC
- CE-SDS
- ELISA
- Cell-based bioassays
These technologies enable comprehensive evaluation of ADC identity, purity, potency, structural integrity, and stability.
Why Choose Protheragen
Our integrated quality control platform provides reliable analytical support throughout the ADC development lifecycle.
- Comprehensive QC solutions from raw materials to finished products
- Advanced analytical technologies for complex ADC characterization
- Expertise in DAR analysis, potency testing, and stability evaluation
- Support for process development, GMP manufacturing, and commercial release
- ICH- and regulatory-guideline-compliant analytical strategies
- Flexible testing programs tailored to individual development stages
- Experienced multidisciplinary analytical scientists
- Fast turnaround and high-quality technical reporting
High-quality analytical testing is essential for successful ADC development and manufacturing. Protheragen combines advanced analytical technologies, experienced scientists, and regulatory expertise to deliver comprehensive quality control solutions that ensure product consistency, accelerate development timelines, and support successful clinical and commercial manufacturing. From early-stage characterization to GMP release testing, we are committed to helping you maintain the highest quality standards throughout every phase of your ADC program. Contact us to discuss your project and discover how our integrated ADC QC services can accelerate your development from laboratory research to clinical and commercial manufacturing.
